Zarrabi, K. K., Ababio, Y., Eccleston, A., Rao, D., Kelly, S., Chang, J., Adejumo, K. L., Lucht, S., Paydar, C., Doren, B. A. V., Bland, E., John, W. S., Feinberg, B. A., Shah, N. J. (2025). Real-world community oncology-based treatment patterns for first line axitinib plus pembrolizumab in advanced renal cell carcinoma: Initial dosing, dose reductions and clinical outcomes.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.487